Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children

Archives of Virology

Volumn 142, Issue 3, 1997, Pages 573-580

  Nigro, G ^a,d   Krzysztofiak, A ^a,b   Bartmann, U ^a   Clerico, A ^a   Properzi, E ^a   Valia, S ^c   Castello, M ^a  

^a Department of Neonatology   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

AIDS RELATED COMPLEX; ARTICLE; CHILD; CYTOMEGALIC INCLUSION BODY DISEASE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOLOGY; INFANT; LIVER; LIVER DISEASE; NEOPLASM; NEWBORN; PRESCHOOL CHILD; ULTRASTRUCTURE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; LIVER; LIVER DISEASES; NEOPLASMS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0030935489     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050103     Document Type: Article

References (12)

1. Albrecht T, Fons MP, Boldogh I, AbuBakar S, Deng CZ, Millinoff D (1991) Metabolic and cellular effects of human cytomegalovirus infection. Transplant Proc 23: 48-55
2. Brytting M, Xu W, Wahren B, Sundqvist V-A (1992) Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol 30: 1937-1941
3. Centers for Disease Control (1994) Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 43: RR-12: 1-10
4. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, Benson CA, Friedberg DN, Hubbard L, Stempien MJ, Shadman A, Buhles W, for the Syntex Cooperative Oral Ganciclovir Study Group (1995) Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 333: 615-620
5. Fletcher CV, Balfour HH Jr (1989) Evaluation of ganciclovir for cytomegalovirus disease. DICP 23: 5-12
6. Gerna, G, Zipeto D, Parea M, Revello MG, Silini E, Percivalle E, Zavattoni M, Grossi P, Milanesi G (1991) Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 164: 488-498
7. Ho M (1991) Cytomegalovirus: biology and infection, 2nd ed. Plenum Press, New York
8. Nigro G, Mattia S, Vitolo R, Bartmann U, Midulla M (1992) Hepatitis in pre-school children: prevalent role of cytomegalovirus. Arch Virol [Suppl] 4: 268-272
9. Nigro G, Bartmann U, Properzi E, Torre A, Schiavetti A, Castello M (1993) Cytomegalovirus infection in two infants with congenital or neonatal solid tumors. Pediatr Hematol Oncol 10: 351-355
10. Nigro G, Taliani G, Krzysztofiak A, Mattia S, Bartmann U, Petruccelli A, Falconieri P, Fridell E, Linque P, Linde A, Dahl H, Wahren B (1993) Multiple viral infections in HIV-infected children with chronically-evolving hepatitis. Arch Virol [Suppl] 8: 237-248
11. Nigro G, Scholz H, Bartmann U (1994) Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: A two-regimen experience. J Pediatr 124: 318-322
12. Spector, SA, Bush DF, Follansbee S, Squires K, Lalezari JP, Jacobson MA, Connor JD, Jung D, Shadman A, Mastre B, Buhles W, Drew WL, AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group (1995) Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study. J Infect Dis 171: 1431-1437